⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

July 6, 2026Annals of Internal Medicine

In acute hypoxemic respiratory failure, high-flow vs. standard oxygen therapy did not reduce mortality at 28 d

Arnav Agarwal Eddy Lang

View Full Paper

Ask AI

Bookmark

Share

Key Points

To determine if high-flow oxygen therapy reduces mortality in patients with acute hypoxemic respiratory failure compared to standard oxygen therapy.
Study design
Compared high-flow oxygen therapy to standard oxygen therapy
Follow-up duration of 28 days
No reduction in mortality at 28 days for high-flow oxygen therapy compared to standard therapy.

Implication

Evaluates mortality effects of high-flow oxygen versus standard therapy in acute hypoxemic respiratory failure, indicating no significant difference.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Agarwal et al. (2026) studied this question.

synapsesocial.com/papers/6a4f39a72b81a944af5745eb https://doi.org/10.7326/annals-26-02382-jc

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1In mechanically ventilated, critically ill adults, conservative vs. usual supplemental oxygen did not reduce mortality at 90 dother · 2025
2High-Flow or Standard Oxygen in Acute Hypoxemic Respiratory FailureOriginal Research · 2026 · 18 citations
3Effect of High-Flow Nasal Oxygen vs Standard Oxygen on 28-Day Mortality in Immunocompromised Patients With Acute Respiratory FailureRCT · 2018 · 333 citations
4Similar mortality with high-flow vs. standard oxygen for acute hypoxemic respiratory failureOriginal Research · 2026
5Comparison of high flow and standard oxygen therapy in patients with acute hypoxemic respiratory failure in emergency department. A randomized controlled cross over superiority trial2024 · 1 citations